Another US Humira Biosimilar Approved As Formularies Offer Access
While Alvotech And Stada Broaden Reach Of Higher-Strength Adalimumab In Europe
• By David Wallace
Fresenius Kabi has received US approval for its Idacio biosimilar • Source: Shutterstock 
